# Identification and Evaluation of Biomarkers of Resistance to Neoadjuvant Chemotherapy (IDEA SEIN)

> **NCT03255486** · NA · COMPLETED · sponsor: **Institut du Cancer de Montpellier - Val d'Aurelle** · enrollment: 164 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** Blood sample

## Key facts

- **NCT ID:** NCT03255486
- **Lead sponsor:** Institut du Cancer de Montpellier - Val d'Aurelle
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 164 (ACTUAL)
- **Last updated:** 2017-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03255486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03255486, "Identification and Evaluation of Biomarkers of Resistance to Neoadjuvant Chemotherapy (IDEA SEIN)". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03255486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*